Figure 3.

Effects of SCTE on cytokine and chemokine levels in BALF. BALF was collected from mice 48 h after the last OVA challenge. Individual samples were analyzed using ELISA. (A) IL-4; (B) IL-13; (C) IL-33, (D) TNF-α, (E) eotaxin. PBS/PBS, PBS-sensitized/challenged, negative control (PBS only); OVA/PBS, OVA-sensitized/challenged mice (PBS only); OVA/mon, OVA-sensitized/challenged mice (montelukast 30 mg/kg); OVA/SCTE-200, OVA-sensitized/challenged mice (SCTE 200 mg/kg); OVA/SCTE-400, OVA-sensitized/challenged mice (SCTE 400 mg/kg). SCTE or montelukast was given 1 h before the challenge. Significantly different from PBS/PBS, ##P < 0.01; significantly different from OVA, *P < 0.05, **P < 0.01.

Lee et al. BMC Complementary and Alternative Medicine 2012 12:257   doi:10.1186/1472-6882-12-257
Download authors' original image